Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Cross-trial comparisons with dual-agonist agents such as tirzepatide are exploratory only no head-to-head trials have been conducted and should be interpreted with caution
AOD-9604 was originally developed to be used as an anti-obesity drug and is known to help burn fat and support weight loss
The dosing structure below is community-derived from each compound's own research plus the CagriSema (cagrilintide + semaglutide ) Phase 3 data
This peptide chain has 15 different amino acids derived from human gastric protein
Custom doses, blends, and private-label peptides available on request
[PubMed] [Google Scholar] [122].Holladay C, Power K, Sefton M
US$ 28.94
US$ 22.81
US$ 23.62
US$ 20.41
US$ 23.18
US$ 21.50
